NCT07185958View on ClinicalTrials.gov

Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

March 21, 2028

Study Completion Date

March 21, 2028

Conditions
Brain MetastasesBone MetastasesHead and Neck CancerLung Cancer
Interventions
DIAGNOSTIC_TEST

Dual-energy CT (DECT)

Additional DECT scan performed for tumor and OAR delineation.

DRUG

Iodine-based contrast agent

Administered intravenously with DECT for enhanced imaging.

DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

Additional MRI scan performed for tumor and OAR delineation.

DRUG

Gadolinium-based contrast agent

Administered intravenously with MRI for enhanced imaging.

Trial Locations (3)

2730

Copenhagen University Hospital Herlev and Gentofte, Herlev

5000

Odense University Hospital, Odense

9000

Aalborg University Hospital, Aalborg

All Listed Sponsors
collaborator

Copenhagen University Hospital at Herlev

OTHER

collaborator

Odense University Hospital

OTHER

lead

Aalborg University Hospital

OTHER